Challenges of antituberculosis treatment in patients with difficult clinical conditions

Clinical Respiratory Journal

Volumn 9, Issue 2, 2015, Pages 143-152

  Vasakova, Martina ^a  

^a FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

Author keywords

Antituberculosis treatment; Elderly; HIV infection; Kidney failure; Liver failure; Pregnancy; Skin toxicity

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC THERAPY; BREAST FEEDING; CHEMOPROPHYLAXIS; COMORBIDITY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY DISEASE; LIVER CIRRHOSIS; LIVER DISEASE; LIVER TOXICITY; LUNG TUBERCULOSIS; MIXED INFECTION; MORTALITY; PREGNANCY; PRIORITY JOURNAL; REVIEW; SKIN MANIFESTATION; SKIN TOXICITY; TUBERCULOSIS; ADULT; AGED; COMPLICATION; FEMALE; MALE; MIDDLE AGED; NEWBORN; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTOR;

ADULT; AGED; ANTITUBERCULAR AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; KIDNEY DISEASES; LIVER DISEASES; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; TUBERCULOSIS;

EID: 84926407695     PISSN: 17526981     EISSN: 1752699X     Source Type: Journal    
DOI: 10.1111/crj.12119     Document Type: Review

References (32)

1. Chandra N, Kumar D, Rao K. Systems biology of tuberculosis. Tuberculosis. 2011;91(5): 487-496.
2. Yew WW, Lange C, Leung CC. Treatment of tuberculosis: update 2010. Eur Respir J. 2011;37: 441-462.
3. World Health Organization. Treatment of Tuberculosis. Guidelines, 4th edn. WHO/HTM/TB/2009.420. Geneva, WHO, 2010.
4. Edelman D, Rossman MD. Tuberculosis. In: Davis GS, editor. Medical Management of Pulmonary Disease. New York., Marcel Dekker., 1999: 613-625.
5. Jindani A, Nunn AJ, Enarson DA. Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet. 2004;364: 1244-1251.
6. Combs DL, O'Brien RJ, Geiter L. USPHS tuberculosis short-course chemotherapy trial 21: effectiveness, toxicity and acceptability: the report of final results. Ann Intern Med. 1990;112: 397-406.
7. Leung CC, Daley CL, Rieder HL, Yew WW. Management of adverse drug events in TB therapy. In: Lange C, Migliori GB, editors. Tuberculosis. European Respiratory Monograph. European Respiratory Society, Sheffield, UK, 2012: 167-193.
8. Yoshikawa TT, Rajagopalan S. Tuberculosis and aging: a global health problem. Clin Infect Dis. 2001;33(7): 1034-1039.
9. Patra S, Lukhmana S, Tayler Smith K, Kannan AT, Satyanarayana S, Enarson DA, Nagar RK, Marcel M, Reid T. Profile and treatment outcomes of elderly patients with tuberculosis in Delhi, India: implications for their management. Trans R Soc Trop Med Hyg. 2013;107(12): 763-768.
10. Kwon YS, Chi SY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC. Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study. BMC Infect Dis. 2013;13: 121. Available at: http://www.biomedcentral.com/1471-23334/13/121 (accessed 20 December 2013).
11. Hauer B, Brodhun B, Altmann D, Fiebig L, Loddenkamper R, Haas W. Tuberculosis in the elderly in Germany. Eur Respir J. 2012;38(2): 467-470.
12. Chan CH, Woo J, Or KK, Chan RC, Cheung W. The effect of age on the presentation of patients with tuberculosis. Tuber Lung Dis. 1995;76(4): 290-294.
13. Zenner D, Kruijshaar ME, Andrews N, Abubakar I. Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med. 2012;185(7): 779-784.
14. Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis. 2012;55(11): 1532-1549.
15. Arbex MA, deCastro Lima Varella M, Ribeiro de Siqueira H, Fiúza de Mello FA. Antituberculosis drugs: drug interactions, adverse effects, and use in special situations. Part 1: first-line drugs. J Bras Pneumol. 2012;36(5): 626-640.
16. Bothamley G. Drug treatment for tuberculosis during pregnancy: safety considerations. Drug Saf. 2001;24(7): 553-565.
17. Loto OM, Awowole I. Tuberculosis in pregnancy: a review. J Pregnancy. 2012;2012: 379271. doi: 10.1155/2012/379271. Epub 1 November 2011
18. Stratford BF. Observations on laboratory rodents treated with 'rifamide' during pregnancy. Med J Aust. 1966;1(1): 10-12.
19. Skevaki CL, Kafetzis DA. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues. Paediatr Drugs. 2005;7(4): 219-234.
20. API Consensus Expert Committee. API TB consensus guidelines 2006: management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations. J Assoc Physicians India. 2006;54: 219-234.
21. Leung CC, Rieder HL, Lange C, Yew WW. Treatment of latent infection with Mycobacterium tuberculosis: update 2010. Eur Respir J. 2011;37: 690-711.
22. Venkata RK, Kumar S, Krishna RP, Kumar SB, Padmanabhan S, Kumar S. Tuberculosis in chronic kidney disease. Clin Nephrol. 2007;67(4): 217-220.
23. Milburn H, Ashman N, Davies P, Doffman S, Drobniewski F, Khoo S, Ormerod P, Ostermann M, Snelson C. Guidelines for the prevention and management of mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease. Thorax. 2010;65: 559-570.
24. Hussein MM, Mooij JM, Roujouleh H. Tuberculosis and chronic renal disease. Semin Dial. 2003;16: 38-44.
25. Bumbacea D, Arend SM, Eyuboglu F, etal. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Repir J. 2012;40: 990-1013.
26. Dhiman RK, Saraswat VA, Rajekar H, Reddy C, Chavla YK. A guide to the management of tuberculosis in patients with chronic liver disease. J Clin Exp Hepatol. 2012;2(3): 260-270.
27. Saukkonen JJ, Cohn DL, Jasmer RM, etal. on behalf of the ATS Hepatotoxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculous therapy. Am J Respir Crit Care Med. 2006;174: 935-952.
28. World Health Organisation. Treatment of tuberculosis: guidelines for national programme. Available at: http://www.who.int/tb/features_archive/new_treatment_guidelines_may2010/en/ (accessed 20 December 2013).
29. Dhingra VK. Treatment of tuberculosis in liver disease. Indian J Tuberc. 2006;53: 232-233.
30. World Health Organization. Tuberculosis and HIV. Available at: http://www.who.int/hiv/topics/tb/en/ (accessed 20 December 2013).
31. Sharma SK, Mohan A, Kadhiravan T. HIV-TB co-infection: epidemiology, diagnosis & management. Indian J Med Res. 2005;121: 550-567.
32. Bereston ES. Reactions to antituberculous drugs. J Invest Dermatol. 1959;33: 427-439.